Aurinia Pharmaceuticals Inc. (AUPH)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

8.42

+0.25

(+3.06%)

At close: 04:00PM EDT

8.44

+0.02

(+0.24%)

After hours:

07:32PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bearishpattern detected

MACD

View all chart patterns

Performance Outlook

Previous Close	8.17
Open	8.27
Bid	8.42 x 4000
Ask	8.45 x 1400
Day's Range	8.24 - 8.45
52 Week Range	7.70 - 33.97
Volume	1,621,507
Avg. Volume	2,772,558

Market Cap	1.195B
Beta (5Y Monthly)	0.94
PE Ratio (TTM)	N/A
EPS (TTM)	-1.26
Earnings Date	Nov 01, 2022 - Nov 07, 2022
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	21.31

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for AUPH

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Aurinia Pharmaceuticals Inc
Daily – Vickers Top Insider Picks for 08/11/2021The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Rating
Fair Value
Economic Moat
last yearArgus Research